SCD is a critical area for both research and clinical investment as emphasized by the NIH’s effort to form Centers of Excellence in nonmalignant hematology (6 Centers, nationally) and the American Society of Hematology’s (ASH) focus on the research need. However, the opportunity to train translational researchers in adult nonmalignant hematology is quite limited, with very few applicants and equally few adult Centers in place for research mentoring and focused comprehensive care in nonmalignant hematology.
The overall goal of the Mentored Career Award in Sickle Cell Disease (SCD) and Nonmalignant Hematology is to train an adult hematologist with a focused clinical and research interest in SCD and nonmalignant hematology and to be competitive at obtaining a peer reviewed award in nonmalignant hematology, bridged by the award.
The program will be located in Milwaukee, Wisconsin as a joint venture between BCW, MCW/FH and the CTSI. This program in SCD/nonmalignant hematology is a unique expansion of the CTSI Awards Program and will only be offered once, as described below.
This position will be supported for 3 years with an evaluation benchmark after the first year. During these 3 years, the candidate will have 75% protected time for research and 25% effort in clinical care/service in SCD and nonmalignant hematology.
The candidate will enter this program as an Instructor in Medicine (salary commensurate) within the Division of Hematology/Oncology (research/clinical effort as described above) for 1 year with appropriate mentoring and evaluation. A research proposal will be developed and finalized during this year. Additionally, the candidate’s clinical suitability will be evaluated. At the end of the first year, with support from the mentoring committee, the applicant will be eligible for promotion to Assistant Professor of Medicine in the Nonmalignant Hematology Section (salary commensurate with rank), with additional academic opportunity to be appointed as an Assistant Investigator, Blood Research Institute (BRI), BCW. The applicant will then have 2 additional years of sponsorship (to complete the 3 years of mentored training) in the CTSI Mentored Career Award Program.
If not previously awarded a Master’s degree, the applicant will enroll (tuition supported by the program) in the Master of Science Program in Clinical and Translational Science within the CTSI during their first year. Additionally, they will interact with the KL2 faculty as well as with those in the Clinical Research Scholars Program.
Up to $75,000 in non-salary research support ($25K per year) will be provided over the 3 years. This award is fully funded by the Blood Center of Wisconsin.
Actionable Goals for Chosen Mentored Career Award Scholar
Submission of a mentored career award such as a K23 or another peer reviewed award (e.g., Doris Duke) at the end of 3 years, or submission of an independent investigator award.
Opportunity to remain at MCW as an Assistant Professor of Medicine and at the BCW (BRI) as an Associate Investigator.
Growth in clinical expertise in SCD and nonmalignant hematology.
Candidates should be internal medicine or med/peds trained, who ideally are either beginning the last year of their hematology/oncology fellowship training or who have just started their 1st year as an Instructor in Medicine.
Focus of research interest must be in SCD
US citizenship or permanent residency
Documented commitment to clinical translational research
Application deadline: TBD
Application must include the following items:
3 letters of recommendation from: a) Fellowship Program Director, b) Hematology/Oncology Division Chief, and c) person of own choosing.
2-page research proposal in sickle cell disease translational research. This will not be expected to be a fully formed proposal as the candidates are early in their career and they will have time to develop their proposal during the last part of their fellowship training as well as during the first year of mentored training in Milwaukee.
Training Institution (s)
Demonstrated focus in nonmalignant hematology
2-3 finalists will be chosen and invited for a formal interview. The interview will include a broader range of SCD clinic personnel and BCW, CTSI and Adult Hematology/Oncology faculty.
NIH Funding Acknowledgment:Important Reminder – Please acknowledge the NIH when publishing papers, patents, projects, and presentations resulting from the use of CTSI resources by including the NIH Funding Acknowledgement.